FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab-containing regimens. Mottok A,* Jurinovic V,* et al. Blood, 2017. *Equal Contribution. [Read More]

Our review paper on predicting transformation was recently published: Can histologic transformation of follicular lymphoma be predicted and prevented? Kridel R, Sehn LH and Gascoyne RD. Blood, 2017.

This was a fantastic meeting organized by Francesco D’Amore from Aarhus and Christian Steidl from Vancouver. Keynote lecture given by Dr. Stephen Ansell from the Mayo Clinic. I had the pleasure to co-chair the session on transformed follicular lymphoma and to present our recently published data on clonal evolution in... [Read More]

Please consider supporting the Heme Team for this year’s Ride to Conquer Cancer. Funds raised through The Ride benefit cancer research at the Princess Margaret Cancer Centre. [Read More]

Kit Tong, research technician, and Tracy Lackraj, post-doctoral fellow, have joined the lab this month. Welcome Kit and Tracy!